Skip to main content

ScienceDex / Researcher record

Segal, Rosalind A.

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #13,359
  • Sustained Excellence
  • R01 Holder
  • Long-Funded

NIH Funding · FY2023

$801K
Full award amounts, FY2023
2
Records listing this PI
#13,359
By linked amount among FY2023 PIs
2006
ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

Linked awards ($M)Award-linked rank
View yearly values
Award-linked funding and rank by fiscal year
Fiscal yearLinked awardsRecordsRank
2006$1,560,8893#2,918
2007$1,229,9472#5,107
2008$1,229,9472#4,778
2009$1,634,7343#4,318
2010$1,425,1523#5,360
2011$2,664,3355#1,815
2012$2,761,8664#1,669
2013$2,776,2695#1,571
2014$2,579,4304#1,900
2015$2,597,6253#1,844
2016$1,224,2082#5,360
2017$1,237,5843#5,281
2018$1,848,3244#3,216
2019$1,780,9204#3,739
2020$1,122,8212#2,378
2021$545,3581#20,181
2022$590,2801#19,731
2023$800,9752#13,359

Award activity

Awards through the years

NIH award records listing this researcher in each fiscal year.

  1. FY20063 records
  2. FY20072 records
  3. FY20082 records
  4. FY20093 records
  5. FY20103 records
  6. FY20115 records
  7. FY20124 records
  8. FY20135 records
  9. FY20144 records
  10. FY20153 records
  11. FY20162 records
  12. FY20173 records
  13. FY20184 records
  14. FY20194 records
  15. FY20202 records
  16. FY20211 record
  17. FY20221 record
  18. FY2023 · selected2 records

Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Segal, Rosalind A.. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets About this stat →

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Publications

Loading publications…

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.

FY2023 award records by amount

NIH award records listing Segal, Rosalind A. as a PI. Multi-PI records show the full award amount for context.

  • 5R01CA205255-07R01Contact PI
    Axonal transport and chemotherapy induced peripheral neuropathy
    $578.5K
    award amount
  • 1R21AG080395-01R21Contact PI
    Formation and function of pathologic stress granules containing RNA-Binding Protein SFPQ in tauopathy
    $222.5K
    award amount

Award organization

Organizations that administered FY2023 awards listing Segal, Rosalind A. as a PI.

FY2023 award administered by Dana-Farber Cancer Institute (MA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2006
    First NIH Award
    Dana-Farber Cancer Institute
  2. 2006
    $500K Cumulative Funding
  3. 2006
    $1M Cumulative Funding
  4. 2006
    Entered Top 50% Nationally
    Ranked #2918
  5. 2006
    Entered Top 25% Nationally
    Ranked #2918
  6. 2007
    $2M Cumulative Funding
  7. 2009
    $5M Cumulative Funding
  8. 2011
    Entered Top 10% Nationally
    Ranked #1815
  9. 2012
    $10M Cumulative Funding
  10. 2012
    R01 Grant Holder
  11. 2019
    $25M Cumulative Funding